Tekla Healthcare Investor...

NYSE: HQH · Real-Time Price · USD
16.43
0.17 (1.05%)
At close: Aug 15, 2025, 3:59 PM
16.40
-0.20%
After-hours: Aug 15, 2025, 05:53 PM EDT

Tekla Healthcare Investors Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Revenue
5.46M 5.31M 4.66M 5.63M 4.32M 3.96M 3.22M 3.26M
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
5.46M 5.31M 4.66M 5.63M 4.32M 3.96M 3.22M 3.26M
Operating Income
-189.15K -31.12K -1.02M -163.15K -1.43M -2.24M -3.34M -2.89M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
85.25M 99.7M -26.83M 83.16M -79.18M -115.05M 66.61M 88.57M
Net Income
85.25M 99.7M -26.83M 83.16M -79.18M -115.05M 66.61M 88.57M
Selling & General & Admin
5.65M 5.34M 5.69M 5.79M 5.75M 6.19M 6.55M 6.16M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
5.65M 5.34M 5.69M 5.79M 5.75M 6.19M 6.55M 6.16M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
37.76K 18.63K n/a n/a n/a n/a n/a n/a
Cost & Expenses
5.65M 5.34M 5.69M 5.79M 5.75M 6.19M 6.55M 6.16M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
53.63M 50.62M 50.53M 48.35M 48.34M 46.34M 46.2M 44.65M
Shares Outstanding (Diluted)
53.63M 50.62M 50.53M 48.35M 48.34M 46.34M 46.2M 44.65M
EPS (Basic)
1.59 1.97 -0.53 1.72 -1.64 -2.48 1.44 1.98
EPS (Diluted)
1.59 1.97 -0.53 1.72 -1.64 -2.48 1.44 1.98
EBITDA
n/a n/a n/a n/a n/a n/a n/a n/a
EBIT
-189.15K -31.12K -1.02M -163.15K -1.43M -2.24M -3.34M -2.89M
Depreciation & Amortization
189.15K 31.12K 1.02M 163.15K 1.43M 2.24M 3.34M 2.89M